Editas Medicine vs Immitra Bio
Editas Medicine vs Immitra Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Editas Medicine is on 42/100 and Immitra Bio on 48/100.
Where each one leads
Editas Medicine
- agent readiness: 39/100 against 29/100
- domain rating: 61/100 against 8/100
- funding raised: $210M against $2.6M
- LinkedIn following: 52,616 against 2,336
Immitra Bio
- our overall score: 48/100 against 42/100
At a glance
| Measure | Editas Medicine | Immitra Bio |
|---|---|---|
| What it is | A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases. | Scalable, one-time curative in-vivo gene editing therapies. |
| Category | Biotech, MedTech, Genomics, Drug Discovery | Biotechnology, Gene Therapy, Genetics, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2013 | 2024 |
| Headquarters | Cambridge, United States | Zürich, Switzerland |
| Status | Active | Active |
Size, funding and growth
| Measure | Editas Medicine | Immitra Bio |
|---|---|---|
| Employees | 185 | Not published |
| Total funding | $210M | $2.6M |
| Latest round | Series B | Pre-Seed |
| LinkedIn followers | 52,616 | 2,336 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Editas Medicine | Immitra Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 48/100 |
| Traction | 60/100 | 32/100 |
| Team | Not published | 70/100 |
| Search visibility | 27/100 | 33/100 |
| Quality | 45/100 | 52/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (29/100) |
| Domain ratingLink authority, 0-100 | 61/100 | 8/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Editas Medicine | Immitra Bio |
|---|---|---|
| CDN | Cloudflare | Fastly |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Bootstrap |
| Analytics | Google Tag Manager | Not detected |
Editas Medicine vs Immitra Bio: common questions
Which is better, Editas Medicine or Immitra Bio?
On our 0-100 score Immitra Bio rates higher (48/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Editas Medicine and Immitra Bio compare on the numbers?
Editas Medicine leads on agent readiness (39/100 against 29/100), domain rating (61/100 against 8/100), funding raised ($210M against $2.6M), LinkedIn following (52,616 against 2,336). Immitra Bio leads on our overall score (48/100 against 42/100).
Read the full Editas Medicine review and pricing or the Immitra Bio review and pricing. You can also browse other Editas Medicine alternatives we track.